Venture-Backed Startups

0 investors

Adaptive is an AI-native healthcare provider that delivers home health services by combining artificial intelligence-driven operations with in-home clinicians to improve patient outcomes and reduce hospital readmissions.

5 investors

Adaptive Insights developed cloud-based corporate performance management software for financial planning, budgeting, forecasting, and reporting. Acquired by Workday in 2018, it now operates as Workday Adaptive Planning.

6 investors

0 investors

0 investors

Adaptive builds adaptive generative AI systems tailored to individual company use cases, moving beyond generic models to incorporate specific organizational knowledge and requirements.

2 investors

Aphage develops AI and sensor technologies to identify, track, and classify physical threats across borders, infrastructure, and transportation networks for government and security organizations.

3 investors

0 investors

Adaptive Security provides security awareness training, phishing attack simulation, and email security solutions designed to defend against AI-powered attacks, deepfakes, and social engineering threats. The company serves enterprise organizations seeking to protect employees and data from next-generation security risks.

6 investors

0 investors

0 investors

0 investors

2 investors

1 investor

Adaptive provides a cloud cost optimization platform that detects, remediates, and prevents "shadow waste" and inefficiencies across multi-cloud, Kubernetes, AI platforms, data cloud, and code. It uses Cloud-to-Code technology, automated pull requests, a runtime sensor, and agentic remediation to govern spending, including LLM, ML, and GPU costs, for engineering teams.

5 investors

0 investors

Adaptive City is a design consultancy offering service and UX design, customer experience, and strategy and transformation services. It is developing Familyar, a mobile phone focused on emotional care and social inclusion.

1 investor

Adaptively Education runs live virtual classes led by teachers in real time. The service is designed for students working toward specific academic objectives outside or alongside traditional schooling.

1 investor

Adaptive Reader produces customized print editions of classic books—offering simplified language, dual-language layouts, dyslexia-friendly and large-print formatting, and synced Read Along Audio—so every reader can access the same text. It is aimed at educators and school systems building classroom sets for students with varied reading levels and language needs.

1 investor

Adaptive Waves develops smart coating technology, validated and advanced through NSF SBIR/STTR Phase I and Phase II grants. The company is seeking strategic partners for market intelligence, joint development, and joint-venture agreements in the coatings industry.

1 investor

Adaptronics produces electro-adhesive gripper interfaces for robots and automated machines that grip objects through electrostatically controlled adhesion, suitable for industrial automation, robotics, agritech, and space applications. The technology uses a flexible printed electronics layer with tactile sensing feedback and requires no pneumatics, magnets, or heat dissipation.

2 investors

Adapty provides infrastructure and analytics for mobile apps that sell in-app subscriptions. Its tools let developers and marketing teams update paywalls without shipping a new app version, deliver discount offers through push notifications, and monitor subscription events and revenue metrics.

2 investors

Adaptyv Bio develops technologies for protein engineering that enable the design and testing of new proteins for applications in medicine, industrial enzymes, and functional materials. The company serves protein engineers and researchers developing therapeutic and industrial biological products.

9 investors

Adaptyx develops a minimally-invasive wearable dermal patch that continuously measures biomarkers in interstitial fluid using an array of programmable molecular switches. The continuous data feeds algorithms intended to help clinicians make timelier decisions and reduce avoidable complications and hospital readmissions, replacing traditional lab draws and repeat clinic visits.

5 investors